ask="0.84"
ask_size="3000"
average_daily_volume="17048"
bid="0.03"
bid_size="4000"
book_value="0.28"
change="-0.03"
change_from_200_day_moving_average="-0.25"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-0.93"
change_From_52_week_low="0.15"
change_in_percent="-4.35%"
close="0.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.73"
high_52_weeks="1.59"
last_trade_date="1/18/2017"
last_trade_price="0.66"
last_trade_size="100"
last_trade_time="3:58pm"
low="0.62"
low_52_weeks="0.51"
market_capitalization="8.84M"
moving_average_200_day="0.91"
moving_average_50_day="0.67"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="6.00"
open="0.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-27.34%"
percent_change_from_50_day_moving_average="-1.58%"
percent_change_from_52_week_high="-58.49%"
percent_change_from_52_week_low="+29.41%"
previous_close="0.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.46"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.40"
stock_exchange="NCM"
symbol="XTLB"
volume="38045"
weeks_range_52="0.51 - 1.59"
